NASA Announces Four Astronauts for Artemis III Moon Mission
NASA announced on Tuesday the four astronauts selected for the Artemis III mission, a crewed spaceflight planned for no earlier than 2027 as part of the agency's program to return humans to the moon. The crew includes NASA astronauts Randy Bresnik (commander), Andre Douglas, and Frank Rubio, along with European Space Agency astronaut Luca Parmitano, and will conduct complex orbital tests rather than land on the lunar surface. The mission represents a critical step in NASA's long-term lunar exploration strategy and demonstrates international partnership in space exploration.
NASA announced the selection of four astronauts for the Artemis III mission, scheduled for launch no earlier than 2027. The crew comprises NASA astronaut Randy Bresnik as commander, ESA astronaut Luca Parmitano as pilot, and NASA astronauts Andre Douglas and Frank Rubio as mission specialists. Contrary to popular perception, Artemis III will not attempt a lunar landing but will instead conduct complex rendezvous and docking operations to test systems and technologies needed for future lunar landing missions. The astronauts bring extensive spaceflight experience: Bresnik has flown twice to the International Space Station, Parmitano commanded ISS Expedition 61, Rubio holds the record for longest single-duration U.S. spaceflight at 371 days, and Douglas will be making his first spaceflight. NASA Administrator Jared Isaacman emphasized the mission's role in demonstrating American innovation and international cooperation, requiring coordination of multiple heavy-lift rocket launches.
What's missing
The articles do not explain why Artemis III will conduct orbital tests rather than attempt a lunar landing, or discuss the timeline and objectives for the actual lunar landing mission that would follow. Additionally, there is limited discussion of the technical challenges or risks associated with the complex rendezvous and docking operations planned for this mission.
How coverage differed
Newsweek's coverage emphasizes the astronauts' qualifications and experience while framing the mission as a demonstration of innovation and international partnership. The headline's reference to crew compensation appears designed to attract reader interest, though the article itself focuses primarily on mission objectives and crew backgrounds rather than payment details.
What different sources said
- NewsweekCenter
NASA Names Artemis III Astronauts: What Crew Will Be Paid for Risky Mission
Related
Scientists Explore Nanotechnology, Robotics, and AI to Address Antibiotic Resistance
Researchers are investigating nanotechnology, robotics, and artificial intelligence as potential tools to combat the growing problem of antibiotic resistance. Aeron Tynes Hammack, a physicist at the Molecular Foundry, is among scientists working on nanoscale solutions including quantum computing applications and viral therapies for infectious diseases. These interdisciplinary approaches represent emerging strategies to address one of modern medicine's most pressing challenges.
Study Shows Brain Learns to Respond Better to Electrical Stimulation Through Distinct Neural Mechanisms
Researchers found that when animals learn a task involving electrical brain stimulation, their neural circuits adapt through two different mechanisms: direct neurons become more excitable while indirectly activated neurons increase in number. The study used advanced imaging and recording techniques to track individual neurons over weeks of learning. These findings suggest that effective brain stimulation therapies may need to account for how the brain naturally adapts to artificial activation.
REM Sleep Theta Oscillations May Help Process Emotional Memories, Study Suggests
A new study found that targeting acoustic cues to specific phases of REM sleep theta waves reduced the emotional intensity of fear-conditioned memories in participants. The research used an automated protocol to time memory reactivation with brain oscillations during sleep. The findings could have implications for treating conditions involving traumatic or maladaptive emotional memories.